QUERYOBJECT SYSTEMS CORP
PRE 14A, 2001-01-19
PREPACKAGED SOFTWARE
Previous: QUERYOBJECT SYSTEMS CORP, 8-K, 2001-01-19
Next: NELX INC, 10QSB, 2001-01-19




                                  SCHEDULE 14A
                                 (Rule 14a-101)

                     INFORMATION REQUIRED IN PROXY STATEMENT

                            SCHEDULE 14A INFORMATION

                    Proxy Statement Pursuant to Section 14(a)
             of the Securities Exchange Act of 1934 (Amendment No. )


Filed by the registrant /X/

Filed by a party other than the registrant / /

Check the appropriate box:

         /X/      Preliminary Proxy Statement
         / /      Confidential, for Use of the Commission Only (as permitted by
                  Rule 14a-6(e)2))
         / /      Definitive Proxy Statement
         / /      Definitive Additional Materials
         / /      Soliciting   Material  Pursuant  to  Rule  14a-11(c)  or  Rule
                  14(a)-12


                         QUERYOBJECT SYSTEMS CORPORATION
--------------------------------------------------------------------------------
                  (Name of Registrant as Specified in Charter)


                            Kenneth Schlesinger, Esq.
                 OLSHAN GRUNDMAN FROME ROSENZWEIG & WOLOSKY LLP
                                 (212) 753-7200
--------------------------------------------------------------------------------
      (Name of Person(s) filing Proxy Statement, if other than Registrant)


         Payment of filing fee (check the appropriate box):

         /X/      No fee required.

         / /      Fee computed on table below per Exchange Act Rules 14a-6(i)(1)
                  and 0-11.

         (1)      Title  of  each  class  of  securities  to  which  transaction
                  applies:

--------------------------------------------------------------------------------

         (2)      Aggregate number of securities to which transaction applies:

--------------------------------------------------------------------------------

         (3)      Per  unit  price  or other  underlying  value  of  transaction
                  computed  pursuant  to  Exchange  Act Rule 0-11 (Set forth the
                  amount on which the filing fee is calculated  and state how it
                  was determined):


<PAGE>


------------------------------------------------------------------------------

         (4)      Proposed maximum aggregate value of transaction:

         (5)      Total fee paid:

         / /      Fee paid previously with preliminary materials.


         / /     Check  box if any  part of the fee is  offset  as  provided  by
Exchange Act Rule  0-11(a)(2)  and identify the filing for which the  offsetting
fee was paid previously.  Identify the previous filing by registration statement
number, or the form or schedule and the date of its filing.

         (1)      Amount Previously Paid:



--------------------------------------------------------------------------------

         (2)      Form, Schedule or Registration Statement no.:



--------------------------------------------------------------------------------

         (3)      Filing Party:



--------------------------------------------------------------------------------

         (4)      Date Filed:


                                       -2-

<PAGE>


                         QUERYOBJECT SYSTEMS CORPORATION
                                 --------------

                    NOTICE OF SPECIAL MEETING OF STOCKHOLDERS
                          TO BE HELD FEBRUARY __, 2001
                                 --------------

To the Stockholders of QueryObject Systems Corporation:

         NOTICE IS HEREBY  GIVEN  that a Special  Meeting of  Stockholders  (the
"Special Meeting") of QueryObject Systems  Corporation,  a Delaware  corporation
(the  "Company"),  will be held at the  Company's  headquarters,  located at One
Expressway  Plaza,  Suite 208, Roslyn  Heights,  New York 11577, on February __,
2001, at 10:00 A.M., local time, for the following purposes:

                  1. To approve the issuance in a private placement of shares of
         Common Stock, $.003 par value (the "Common Stock"),  of the Company and
         securities  exercisable for Common Stock  representing more than 20% of
         the number of issued and outstanding shares of Common Stock; and

                  2. To transact such other  business as may properly be brought
         before the Special Meeting or any adjournment thereof.

         The Board of  Directors  has fixed the close of business on January 12,
2001 as the record date for the  Special  Meeting or any  adjournments  thereof.
Only  stockholders  of record on the stock  transfer books of the Company at the
close of  business  on that date are  entitled to notice of, and to vote at, the
Special Meeting.

                                       By Order of the Board of Directors



                                       DANIEL M. PESS
                                       Secretary

Dated: January __, 2001
Roslyn Heights, New York

         WHETHER OR NOT YOU EXPECT TO BE PRESENT AT THE SPECIAL MEETING, YOU ARE
URGED TO FILL IN, DATE,  SIGN AND RETURN THE ENCLOSED PROXY IN THE ENVELOPE THAT
IS PROVIDED, WHICH REQUIRES NO POSTAGE IF MAILED IN THE UNITED STATES.



<PAGE>

                         QUERYOBJECT SYSTEMS CORPORATION
                         ONE EXPRESSWAY PLAZA, SUITE 208
                         ROSLYN HEIGHTS, NEW YORK 11577
                                ----------------

                                 PROXY STATEMENT
                                       FOR
                         SPECIAL MEETING OF STOCKHOLDERS

                                FEBRUARY __, 2001
                                ----------------

                                  INTRODUCTION

         This Proxy Statement is being furnished to stockholders by the Board of
Directors  of  QUERYOBJECT  SYSTEMS  CORPORATION,  a Delaware  corporation  (the
"Company"),  in connection with the solicitation of the  accompanying  Proxy for
use at a Special Meeting of Stockholders of the Company (the "Special  Meeting")
to be  held  at  the  Company's  principal  executive  offices  located  at  One
Expressway  Plaza,  Suite 208, Roslyn  Heights,  New York 11577, on February __,
2001, at 10:00 A.M., local time, or at any adjournment thereof.

         The approximate date on which this Proxy Statement and the accompanying
Proxy will first be sent or given to stockholders is January __, 2001.

                        RECORD DATE AND VOTING SECURITIES

         Only  stockholders  of record at the close of  business  on January 12,
2001,  the record  date (the  "Record  Date") for the Special  Meeting,  will be
entitled to notice of, and to vote at, the Special  Meeting and any  adjournment
thereof.  As of the close of business on the Record Date,  there were 10,361,657
outstanding  shares of the Company's common stock,  $.003 par value (the "Common
Stock"). In January 2000, the Company consummated a one-for-three  reverse stock
split of its  Common  Stock.  All share and per share  amounts  and  option  and
warrant  information  in this Proxy  Statement have been restated to reflect the
one-for-three reverse stock split.

                                VOTING OF PROXIES

         Shares  of  Common  Stock  represented  by  Proxies  that are  properly
executed,  duly  returned and not revoked will be voted in  accordance  with the
instructions  contained therein.  If no specification is indicated on the Proxy,
all such shares will be voted (i) for the  approval of the issuance in a private
placement of shares of Common Stock and securities  exercisable for Common Stock
representing  more than 20% of the  number of issued and  outstanding  shares of
Common Stock (the "Share Issuance Proposal") and (ii) upon any other matter that
may  properly  be brought  before the  Special  Meeting in  accordance  with the
judgment of the person or persons voting the Proxies.



<PAGE>

         The execution of a Proxy will in no way affect a stockholder's right to
attend the Meeting and to vote in person.  Any Proxy  executed and returned by a
stockholder  may  be  revoked  at any  time  thereafter  if  written  notice  of
revocation  is given to the  Secretary  of the  Company  prior to the vote to be
taken at the Special  Meeting,  or by execution  of a  subsequent  proxy that is
presented  to the  Special  Meeting or if the  stockholder  attends  the Special
Meeting  and votes by ballot,  except as to any  matter or matters  upon which a
vote will have been cast under the  authority  conferred  by such Proxy prior to
such revocation.

         The cost of  solicitation  of the Proxies being  solicited on behalf of
the Board of Directors  will be borne by the Company.  In addition to the use of
the mails, proxy  solicitation may be made by telephone,  telegraph and personal
interview by officers, directors and employees of the Company. The Company will,
upon request,  reimburse  brokerage  houses and persons  holding Common Stock as
nominees for their reasonable  expenses in sending soliciting  material to their
principals.

                                  VOTING RIGHTS

         Holders  of shares of Common  Stock are  entitled  to one vote for each
share held on all matters.

         The holders of a majority of the  outstanding  shares of Common  Stock,
whether present in person or represented by proxy,  will constitute a quorum for
purposes of the Share  Issuance  Proposal  and any other  matters  that may come
before the meeting.

         Broker  "non-votes"  and the shares as to which a stockholder  abstains
from voting are included for purposes of determining  whether a quorum of shares
is present at a  meeting.  A broker  "non-vote"  occurs  when a nominee  holding
shares for a beneficial  owner does not vote on a particular  proposal,  because
the nominee does not have  discretionary  voting power with respect to that item
and has not received instructions from the beneficial owner.

         The  affirmative  vote of a  majority  of the votes  cast by holders of
Common Stock is required to approve the Share Issuance  Proposal.  In tabulating
the votes on the proposal to approve the Share  Issuance  Proposal,  abstentions
and broker  non-votes  will be treated as shares  that are present but that have
not been voted and accordingly are not included in determining whether the Share
Issuance Proposal is approved.

                              SECURITY OWNERSHIP OF
                    CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

         The following table sets forth information  concerning ownership of the
Company's  Common  Stock as of the  Record  Date,  by each  person  known by the
Company to be the beneficial  owner of more than five percent of the outstanding
Common Stock,  each director,  each  executive  officer and by all directors and
executive officers of the Company as a group.  Certain beneficial owners of more
than five percent of the outstanding  Common Stock have expressed an interest in
purchasing  securities in the private placement that is the subject of the Share
Issuance  Proposal.  The  table  does not  reflect  any such  purchases.  Unless
otherwise indicated, the address

                                       -2-

<PAGE>

for each such person is in care of the Company, One Expressway Plaza, Suite 208,
Roslyn Heights, New York 11577.

<TABLE>
<CAPTION>

                                                                       Number of Shares
                Directors, Executive Officers                           of Common Stock
                     and 5% Stockholders                             Beneficially Owned(1)             Percentage

<S>                                                                        <C>                           <C>
Barry Rubenstein.............................................              2,947,443(2)                  28.3%
68 Wheatley Road
Brookville, New York 11545
Irwin Lieber.................................................              2,023,002(3)                  19.5%
767 Fifth Avenue, 45th Floor
New York, New York 10153
Barry Fingerhut..............................................              1,987,502(4)                  19.2%
767 Fifth Avenue, 45th Floor
New York, New York 10153
Seth Lieber..................................................              1,916,216(5)                  18.5%
767 Fifth Avenue, 45th Floor
New York, New York 10153
Jonathan Lieber..............................................              1,916,216(6)                  18.5%
767 Fifth Avenue, 45th Floor
New York, New York 10153
Wheatley Foreign Partners, L.P...............................              1,915,521(7)                  18.5%
c/o Fiduciary Trust
One Capital Place
Snedden Road
P.O. Box 1062
Grand Cayman
British West Indies
Wheatley Partners, L.P.......................................              1,915,521(7)                  18.5%
80 Cutter Mill Road
Great Neck, New York 11021
Joseph M. Valley, Jr.........................................                 20,000                     (8)
Robert Thompson..............................................                210,426(9)                   2.0%
Daniel M. Pess...............................................               212,565(10)                   2.0%
Rino Bergonzi................................................                 14,436(9)                   (8)
Alan W. Kaufman..............................................               186,837(11)                   1.8%
Amy L. Newmark...............................................               182,631(12)                   1.7%
</TABLE>


                                       -3-

<PAGE>

<TABLE>
<CAPTION>

                                                                       Number of Shares
                Directors, Executive Officers                           of Common Stock
                     and 5% Stockholders                             Beneficially Owned(1)             Percentage

<S>                                                                        <C>                           <C>
Andre Szykier ...............................................              112,791(13)                   1.1%
All directors and executive officers as a group (7
persons).....................................................              939,686(14)                   8.5%
</TABLE>


(1)      A person is deemed to be the beneficial owner of voting securities that
         can be  acquired  by such  person  within 60 days after the Record Date
         upon the exercise of options, warrants or convertible securities.  Each
         beneficial owner's percentage  ownership is determined by assuming that
         options,  warrants  or  convertible  securities  that  are held by such
         person (but not those held by any other  person) and that are currently
         exercisable (i.e., that are exercisable within 60 days after the Record
         Date) have been exercised. Unless otherwise noted, the Company believes
         that all  persons  named in the table have sole  voting and  investment
         power with respect to all shares beneficially owned by them.

(2)      Based upon  information  contained  in a report on a Schedule 13D filed
         jointly by Barry Rubenstein, Wheatley Foreign Partners, L.P. ("Wheatley
         Foreign"),  Wheatley  Partners,  L.P.  ("Wheatley"),   Seneca  Ventures
         ("Seneca"), Woodland Venture Fund ("Woodland Fund"), Woodland Partners,
         Rev-Wood  Merchant  Partners  ("Rev-Wood"),  Brookwood  Partners,  L.P.
         ("Brookwood")  and  certain  other  entities  with the  Securities  and
         Exchange  Commission  ("SEC") and a Form 4 filed by Mr. Rubenstein with
         the SEC.  Includes 37,152 shares of Common Stock issuable upon exercise
         of options held by Mr.  Rubenstein.  Also  includes (i) 1,040 shares of
         Common  Stock  issuable  upon  exercise  of  warrants  held by Woodland
         Partners,  (ii) 1,040 shares of Common Stock  issuable upon exercise of
         warrants  held by Woodland  Fund,  (iii) 1,040  shares of Common  Stock
         issuable upon exercise of warrants held by Seneca, (iv) 1,959 shares of
         Common Stock  issuable upon exercise of warrants held by Wheatley,  (v)
         123 shares of Common Stock  issuable  upon exercise of warrants held by
         Wheatley Foreign,  and (vi) 16,666 shares of Common Stock issuable upon
         exercise  of  options  held  by  Rev-Wood.   Mr.  Rubenstein  disclaims
         beneficial  ownership  of the  securities  held by  Woodland  Partners,
         Woodland  Fund,  Seneca,  Wheatley,  Wheatley  Foreign,  Rev-Wood,  and
         Brookwood,  except to the  extent of his  respective  equity  interests
         therein.

(3)      Based upon  information  contained in the Wheatley 13D and Form 4 filed
         by Mr. Lieber and certain other information.  Includes 35,500 shares of
         Common Stock issuable upon exercise of options held by Mr. Lieber. Also
         includes  (i) 1,959 shares of Common Stock  issuable  upon  exercise of
         warrants held by Wheatley, and (ii) 123 shares of Common Stock issuable
         upon exercise of warrants held by Wheatley Foreign, of which Mr. Lieber
         disclaims beneficial ownership,  except to the extent of his respective
         equity interests therein.

(4)      Based upon information contained in the Wheatley 13D and a Form 4 filed
         by Mr. Fingerhut and certain other information. Also includes (i) 1,959
         shares of Common  Stock  issuable  upon  exercise of  warrants  held by
         Wheatley, and (ii) 123 shares of Common Stock issuable upon exercise of
         warrants held by Wheatley Foreign.  Mr. Fingerhut disclaims  beneficial
         ownership of the  securities  held by Wheatley  and  Wheatley  Foreign,
         except to the extent of his respective equity interests therein.


                                       -4-

<PAGE>


(5)      Based upon information contained in the Wheatley 13D and a Form 4 filed
         by Mr.  Lieber.  Includes  668  shares of Common  Stock  issuable  upon
         exercise of options held by Mr. Lieber.  Also includes (i) 1,959 shares
         of Common Stock  issuable  upon  exercise of warrants held by Wheatley,
         and (ii) 123 shares of Common Stock  issuable upon exercise of warrants
         held by Wheatley  Foreign,  of which Mr.  Lieber  disclaims  beneficial
         ownership,  except to the  extent of his  respective  equity  interests
         therein.

(6)      Based upon information contained in the Wheatley 13D and a Form 4 filed
         by Mr.  Lieber.  Includes  668  shares of Common  Stock  issuable  upon
         exercise of options held by Mr. Lieber.  Also includes (i) 1,959 shares
         of Common Stock  issuable  upon  exercise of warrants held by Wheatley,
         and (ii) 123 shares of Common Stock  issuable upon exercise of warrants
         held by Wheatley  Foreign,  of which Mr.  Lieber  disclaims  beneficial
         ownership,  except to the  extent of his  respective  equity  interests
         therein.

(7)      Based upon information contained in the Wheatley 13D and a Form 4 filed
         by each of Wheatley and Wheatley Foreign and certain other information.
         Includes  (i) 1,959 shares of Common Stock  issuable  upon  exercise of
         warrants held by Wheatley, and (ii) 123 shares of Common Stock issuable
         upon exercise of warrants held by Wheatley  Foreign.  Wheatley  Foreign
         disclaims  beneficial  ownership of the securities held by Wheatley and
         Wheatley  disclaims  beneficial  ownership  of the  securities  held by
         Wheatley Foreign.

(8)      Less than 1%.

(9)      Consists of shares of Common Stock issuable upon exercise of options.

(10)     Includes  209,982  shares of Common  Stock  issuable  upon  exercise of
         options.

(11)     Includes  78,510  shares of Common  Stock  issuable  upon  exercise  of
         options.

(12)     Includes  104,436  shares of Common  Stock  issuable  upon  exercise of
         options.

(13)     Includes  104  shares  of  Common  Stock  owned  by Remy  Szykier,  Mr.
         Syzkier's  daughter,  and 44,208  shares of Common Stock  issuable upon
         exercise of options.

(14)     Includes  661,998  shares of Common  Stock  issuable  upon  exercise of
         options.




                                       -5-

<PAGE>

                                   PROPOSAL I
                       APPROVAL OF SHARE ISSUANCE PROPOSAL

Background

         As indicated in the Company's  Quarterly  Report on Form 10-QSB for the
quarterly period ended September 30, 2000 (the "Form 10-QSB"), the Company is in
need of  additional  financing  to fund its  operations.  The Form  10-QSB  also
indicated  that  on  a  consolidated  basis,  the  Company  had  cash  and  cash
equivalents of $5,927,113.  However, a significant portion of such cash and cash
equivalents    represent   funds   received   by   the   Company's   subsidiary,
internetQueryObject Corporation ("IQO"), for use primarily for IQO's operations,
in a private placement  consummated in April 2000. As stated in the Form 10-QSB,
on a non-consolidated  basis, the Company's cash and cash equivalent balance was
insufficient  to satisfy its cash flow  requirements  beyond  December  2000. In
December  2000, the Company  consummated  an interim  financing of $250,000 from
Wheatley  and  Wheatley  Foreign,  two  principal  stockholders  of the Company.
Wheatley and Wheatley Foreign were issued promissory notes aggregating  $250,000
principal  amount  bearing  interest at the rate of 12% per annum (the  "Interim
Financing Notes").  The Company currently  estimates that the proceeds from such
interim  financing will be sufficient to satisfy the Company's cash requirements
on a non-  consolidated  basis until January 31, 2001. The Board of Directors of
the Company has considered various means of procuring  additional  financing and
has determined that a private  placement of the Company's  securities will be in
the best  interests  of the Company.  The net proceeds of the private  placement
will be used for sales and  marketing,  research  and  development  and  general
working capital  purposes in the proportions of 50%, 20% and 30%,  respectively.
The Company will not allocate any of the proceeds from the private  placement to
IQO.

Terms of the Offering

         In  January  2001,  the  Company  commenced  a private  placement  (the
"Offering")  of units (the "Units")  consisting of one share of Common Stock and
two redeemable  Common Stock purchase  warrants (the  "Warrants").  The per-Unit
offering price will be 75% of the average closing price of the Company's  Common
Stock for the five  consecutive  business  days ended two business days prior to
the first closing (the "First Closing") (such average referred to hereinafter as
the "First Market Price"),  subject to subsequent adjustment.  Under Rule 713 of
the Listing Standards,  Policies and Requirements of the American Stock Exchange
(the  "AMEX"),  on which the Common Stock is listed,  the Company is required to
obtain  stockholder  approval in connection with any  transaction,  other than a
public  offering,  that  involves  the  issuance by the Company of Common  Stock
(and/or securities convertible into or exercisable for Common Stock) that equals
20% or more of the Common Stock of the Company  outstanding  before the issuance
of such  securities  at a price below the greater of book or market value of the
Common Stock. The minimum number of Units ( the "Minimum Number"), 2,050,000, is
the number of Units that the  Company  can sell  without  obtaining  stockholder
approval under Rule 713, and the maximum number of Units (the "Maximum  Number")
will equal the number determined by dividing $3,000,000,  which may be increased
to $5,000,000 upon agreement of the Company and the exclusive placement agent in
the offering  (the  "Placement  Agent"),  by the per-Unit  offering  price.  The
principal of and interest on the Interim  Financing  Notes may be converted into
Units.



                                       -6-

<PAGE>

         The Company may not sell Units in the Offering in excess of the Minimum
Number  without  stockholder  approval.  Accordingly,  the  Company  is  seeking
stockholder  approval  for  the  Share  Issuance  Proposal.   If  the  Company's
stockholders  approve the Share Issuance Proposal,  the Company will be entitled
to hold an additional  closing (the "Final Closing") with respect to the sale of
any Units in excess of the  Minimum  Number.  In  approving  the Share  Issuance
Proposal,  the stockholders  will also be approving any decrease in the exercise
price of the  Warrants to an exercise  price that is lower than the First Market
Price, as described  below. In the absence of stockholder  approval of the Share
Issuance Proposal, the Company will only hold the First Closing. There can be no
assurance  that  the  Company  will  consummate  the  First  Closing  or,  if it
consummates the First Closing, that it will consummate the Final Closing.

         Notwithstanding  any  of the  foregoing,  if (i)  the  Company  obtains
stockholder  approval  of the Share  Issuance  Proposal,  (ii)  there is a Final
Closing, and (iii) if the average closing price of the Common Stock for the five
consecutive  business  days ended two business  days prior to the Final  Closing
(such average  referred to hereinafter as the "Final Market Price") is less than
the First Market Price,  then the per-Unit  offering  price of all Units will be
reduced to 75% of the Final Market Price and all investors  who purchased  Units
in the First  Closing  will be issued  additional  Units to adjust to 75% of the
Final  Market  Price  the  per-Unit  purchase  price  paid by them at the  First
Closing.

         Each  Warrant  offered  entitles  the holder to  purchase  one share of
Common  Stock for an  initial  exercise  price  equal to $0.125  above the First
Market Price during the five-year period (the "Exercise  Period")  commencing on
the date of the First Closing, subject to prior redemption;  provided,  however,
that the exercise price will be decreased to $0.125 above the Final Market Price
if (i) the Final Market Price is lower than the First Market  Price,  (ii) there
is a Final  Closing and (iii) the Company  obtains  stockholder  approval of the
Share Issuance  Proposal.  As a result of this provision,  the exercise price of
the  Warrants  granted in the First  Closing may be lower than the First  Market
Price.  The  Warrants  are  redeemable  at any time at a sale  price of $.01 per
Warrant  on not less than 30 days'  notice so long as a  Registration  Statement
under the Securities Act of 1933, as amended,  is in effect  covering the resale
of the Common Stock  issuable  upon the exercise of the Warrants and the closing
sale price of the Common Stock has been at least 160% of the  exercise  price of
the Warrants for 20  consecutive  days ending  within two business days prior to
the date on which the Company gives notice of redemption.

         The Company has agreed to file a  Registration  Statement no later than
April 16, 2001,  registering for resale the shares of Common Stock (i) purchased
in the  Offering,  (ii)  underlying  the  warrants  and the Extra  Warrants  (as
hereinafter  defined) and (iii)  underlying  an option  issued to the  placement
agent (the  "Placement  Agent  Option") to purchase 10% of the Units sold in the
First Closing and Final Closing.

         The  Company  must  use  its  best  efforts  to have  the  Registration
Statement  declared  effective  by the SEC no later than the earlier of June 19,
2001  or  60  days  after  the  initial  filing  (the  "Target  Date").  If  the
Registration Statement is not declared effective by the Target Date, then on the
Target Date and on each monthly anniversary of the Target Date thereafter, until
the earlier of the  effective  date of the  Registration  Statement  or the 19th
monthly anniversary of the Target Date, the Company is required to issue to each
holder of Units purchased and to the placement agent or its designee as


                                       -7-

<PAGE>

holder of the purchase  option,  warrants  (the "Extra  Warrants") to purchase a
number of shares of Common Stock equal to 5% of the number of Warrants purchased
by the holder in the private  placement  (and, as to the Placement  Agent, 5% of
the  number of  Warrants  underlying  the  Placement  Agent  Option).  The Extra
Warrants will have the same terms as the Warrants.  Each purchaser of Units will
be required to execute a lock-up agreement, under which the purchaser agrees not
to sell the  underlying  shares  of Common  Stock,  the  Warrants  and any Extra
Warrants  for a period of 12 months  after the First  Closing  without the prior
written consent of the Placement Agent.

         The Placement Agent in the private  placement will receive  commissions
of 8% and a non-  accountable  expense  allowance of 3% of the gross proceeds of
the private placement.

Approval  of the  Proposal  Could  Result In  Significant  Dilution  to Existing
Stockholders

         As of the Record Date, the Company had outstanding 10,361,657 shares of
Common  Stock.  The AMEX has advised the Company that the  Warrants  will not be
counted  toward the 20%  Limitation  because the exercise  price of the Warrants
will be in excess of the market  value and book value of the Common Stock on the
date  that  the  Warrants  are  granted.   Accordingly,  the  Company  may  sell
approximately  2,050,000 Units in the Offering without  stockholder  approval of
the Share  Issuance  Proposal.  If the  stockholders  approve the Share Issuance
Proposal  and  assuming the per- Unit  offering  price is $0.5625 per Unit,  the
Company could sell up to 5,333,333 Units (or an additional 3,283,333 Units above
the  Minimum  Number) and the  Company  and the  Placement  Agent would have the
discretion  to  increase  the number of Units sold in the  Offering  so that the
Company could sell up to 8,888,889 Units (or an additional 6,838,889 Units above
the Minimum Number). As a result,  stockholders could incur significant dilution
if the stockholders  approve the Share Issuance  Proposal.  Stockholders  should
therefore consider the potential dilution before they approve the Share Issuance
Proposal.

The Company  Needs  Additional  Financing to Satisfy its Cash  Requirements  and
Possibly Maintain the Listing of its Common Stock on the American Stock Exchange

         The  Company  anticipates  that  if it  sells  4,000,000  Units  in the
Offering at an assumed offering price of $0.5625 per Unit, its cash requirements
should be satisfied until 12 months after the Final Closing, but if it sells the
Minimum Number (2,050,000 Units) in the Offering at an assumed offering price of
$0.5625  per Unit its cash  requirements  should be  satisfied  only until three
months  from the First  Closing.  Accordingly,  if the  Company  fails to obtain
stockholder  approval  for the Share  Issuance  Proposal,  the Company  would be
required to immediately seek additional financing.  However, it is unlikely that
the  Company  would  be able to  obtain  such  financing  on a  timely  basis on
commercially  reasonable  terms.  If  the  Company  is  unable  to  obtain  such
financing, the Company may have to cease operations. In addition, if the Company
fails to obtain  stockholder  approval,  the Company  could be delisted from the
AMEX.

         In order to maintain the listing of the Common  Stock on the AMEX,  the
Company must maintain a satisfactory  financial condition and operating results,
and meet other standards with respect to  stockholders'  equity,  net losses and
the  aggregate  market value of the Common  Stock.  While the Company  currently
satisfies the AMEX's listing and maintenance standards, if the Company is unable
to obtain additional financing either through the Offering or otherwise, the

                                       -8-

<PAGE>

Company may fail to meet these  criteria in the future,  which may result in the
Common  Stock no longer being  eligible  for listing on the AMEX.  If the Common
Stock is delisted from the AMEX,  there would be material  adverse  consequences
for the Company and its stockholders.  These consequences  include,  but are not
limited to:

        o         limited  availability  of market  quotations for the Company's
                  common stock;

        o         limited news coverage of the Company;

        o         an adverse  affect on the trading  market for and market price
                  of the Company's common stock; and

        o         an adverse affect on the Company's ability to issue additional
                  securities or secure additional financing in the future.

Interest of Certain Persons in Matters to be Acted Upon

         Certain  principal   stockholders  of  the  Company  have  expressed  a
preliminary  interest in  purchasing  securities  in the  Offering.  Should such
principal stockholders choose to invest in the Offering,  their investment would
be on the same terms and  conditions as are available to other  investors in the
Offering.

Vote Required

         The  affirmative  vote of a  majority  of the votes  cast by holders of
Common Stock is required to approve the Share Issuance  Proposal.  In tabulating
the votes to  approve  the  Share  Issuance  Proposal,  abstentions  and  broker
non-votes  are not  considered  shares  entitled to vote and are not included in
determining whether the Share Issuance Proposal is approved.

Recommendation of the Board of Directors

         The Board of Directors has considered  the Share Issuance  Proposal and
believes that it is in the best interests of its stockholders.

         The  Board  of  Directors  unanimously  recommend  that  the  Company's
stockholders vote FOR the Share Issuance Proposal.






                                       -9-

<PAGE>

                           ANNUAL AND QUARTERLY REPORT

         All  stockholders  of  record as of the  Record  Date,  are being  sent
herewith a copy of the  Company's  (i) Annual Report on Form 10-KSB for the year
ended December 31, 1999, which contains  certified  financial  statements of the
Company for the year then ended and (ii) Quarterly Report on Form 10-QSB for the
quarter ended September 30, 2000. This Proxy Statement incorporates by reference
the Financial  Statements and Management's  Discussion and Analysis of Financial
Condition and Results of Operations contained in such reports.

         ANY  STOCKHOLDER OF THE COMPANY MAY OBTAIN WITHOUT CHARGE A COPY OF THE
COMPANY'S  ANNUAL  REPORT ON FORM  10-KSB FOR THE YEAR ENDED  DECEMBER  31, 1999
(WITHOUT  EXHIBITS)  AND  QUARTERLY  REPORT ON FORM 10-QSB FOR THE QUARTER ENDED
SEPTEMBER 30, 2000, AS FILED WITH THE  SECURITIES  AND EXCHANGE  COMMISSION,  BY
WRITING TO DANIEL M. PESS, CHIEF FINANCIAL OFFICER AND SECRETARY, AT QUERYOBJECT
SYSTEMS  CORPORATION,  ONE EXPRESSWAY PLAZA, SUITE 208, ROSLYN HEIGHTS, NEW YORK
11577.

                                  OTHER MATTERS

                  As of the date of this Proxy Statement, management knows of no
matters   other  than  those  set  forth  herein  that  will  be  presented  for
consideration  at the  Meeting.  If any other  matter or  matters  are  properly
brought before the Meeting or any adjournment  thereof, the persons named in the
accompanying Proxy will have discretionary  authority to vote, or otherwise act,
with respect to such matters in accordance with their judgment.



Daniel M. Pess
Secretary

January __, 2001


                                      -10-

<PAGE>

           THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS

                         QUERYOBJECT SYSTEMS CORPORATION

                    Proxy -- Special Meeting of Stockholders
                                February __, 2001

                  The   undersigned,   a  stockholder  of  QueryObject   Systems
Corporation, a Delaware corporation (the "Company"),  does hereby appoint Robert
Thompson and Daniel M. Pess, and each of them, the true and lawful attorneys and
proxies with full power of substitution, for and in the name, place and stead of
the undersigned,  to vote all of the shares of Common Stock of the Company which
the undersigned  would be entitled to vote if personally  present at the Special
Meeting of Stockholders of the Company (the "Special Meeting") to be held at the
Company's  principal  executive offices,  located at One Expressway Plaza, Suite
208, Roslyn Heights,  New York 11577, on February __, 2001 at 10:00 A.M.,  local
time, or at any adjournment or adjournments thereof.

                  The  undersigned   hereby  instructs  said  proxies  or  their
substitutes:

         1.       TO APPROVE THE SHARE ISSUANCE PROPOSAL.


               ______  FOR   _____  AGAINST    _____  ABSTAIN


         2.        DISCRETIONARY AUTHORITY:

              In their discretion,  the proxies are authorized to vote upon such
other and further business as may properly come before the Special Meeting.


         THIS PROXY WILL BE VOTED IN ACCORDANCE WITH ANY DIRECTIONS HEREINBEFORE
GIVEN. UNLESS OTHERWISE SPECIFIED, THIS PROXY WILL BE VOTED TO APPROVE THE SHARE
ISSUANCE PROPOSAL.

         The undersigned  hereby revokes any proxy or proxies  heretofore given,
and ratifies and confirms that all the proxies appointed hereby, or any of them,
or their substitutes,  may lawfully do or cause to be done by virtue hereof. The
undersigned  hereby  acknowledges  receipt  of a copy of the  Notice of  Special
Meeting  and  Proxy  Statement,  both  dated  January  __,  2001,  a copy of the
Company's  Annual Report on Form 10-KSB for the year ended December 31, 1999 and
a copy of the  Company's  Quarterly  Report on Form 10-QSB for the quarter ended
September 30, 2000.

Dated _______________________ 2001


_____________________________ (L.S.)


                                      -11-




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission